Key result
A 5-month-old infant with acute fulminant myocarditis and a massively dilated left ventricle developed a fatal left ventricular thrombus and subsequent cerebral infarctions despite systemic anticoagulation during ECMO support.
Case Report (n=1)
No
This case highlights the severe risk of fatal left ventricular thrombosis and thromboembolism in infants with massively dilated LVs receiving ECMO support.
LV thrombus and stroke risk remains high in infants with dilated LV on ECMO despite anticoagulation; leaves optimal prevention strategies open.
Thromboembolism in patients receiving extracorporeal membrane oxygenation (ECMO) support is a feared complication. Systemic anticoagulation during ECMO in patients with a massively dilated left ventricle (LV) and decreased LV systolic function is still debated. Hearin, we report a case of a 5-month old infant on ECMO support who had fatal thrombus formation in the massively dilated LV and a consequent thromboembolic event.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2013) conducted a case report in Acute fulminant myocarditis with massively dilated left ventricle (n=1). Extracorporeal membrane oxygenation (ECMO) was evaluated on Thrombus formation and thromboembolic events. A 5-month-old infant with acute fulminant myocarditis and a massively dilated left ventricle developed a fatal left ventricular thrombus and subsequent cerebral infarctions despite systemic anticoagulation during ECMO support.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: